Further experimental validation in a rat model revealed that YYHXD could inhibit PI3K/Akt activation, thereby exerting antioxidant and anti-apoptotic effects to alleviate liver fibrosis. The gene discussed is AKT1; the disease is Hepatic fibrosis.